Stockscreener 앱 받기
2.05
6.77%
0.13
시간 외 거래:
2.05
전일 마감가:
$1.92
열려 있는:
$1.91
하루 거래량:
646.14K
Relative Volume:
1.30
시가총액:
$129.61M
수익:
$4.39M
순이익/손실:
$-22.40M
주가수익비율:
-4.0212
EPS:
-0.5098
순현금흐름:
$-22.79M
1주 성능:
+13.89%
1개월 성능:
-17.00%
6개월 성능:
+61.42%
1년 성능:
+342.76%
1일 변동 폭
$1.91
$2.17
1주일 범위
$1.695
$2.17
52주 변동 폭
$0.27
$2.70
Equillium Inc Stock (EQ) Company Profile
명칭
Equillium Inc
전화
(858) 412-5302
주소
2223 AVENIDA DE LA PLAYA, LA JOLLA, CA
Compare EQ vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EQ
Equillium Inc
|
2.05 | 121.39M | 4.39M | -22.40M | -22.79M | -0.5098 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Equillium Inc Stock (EQ) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2026-03-13 | 개시 | Roth Capital | Buy |
| 2026-02-25 | 개시 | Stifel | Buy |
| 2025-03-28 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2021-10-29 | 재개 | Stifel | Buy |
| 2021-09-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-07-14 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-10 | 재개 | Stifel | Buy |
| 2019-02-22 | 개시 | SVB Leerink | Outperform |
모두보기
Equillium Inc 주식(EQ)의 최신 뉴스
[ARS] Equillium, Inc. SEC Filing - Stock Titan
Reverse split and share increase up for Equillium (NASDAQ: EQ) stockholder vote - Stock Titan
Equillium (EQ) price target increased by 10.71% to 7.90 - MSN
Raymond James Initiates Coverage of Equillium (EQ) with Strong Buy Recommendation - MSN
EQ Initiates Coverage On by Raymond James -- Strong Buy Rating A - GuruFocus
Raymond James Initiates Equillium at Strong Buy With $6 Price Target - Moomoo
EQ Initiates Coverage On by Raymond James -- Strong Buy Rating Announced - GuruFocus
Here’s what Roth Capital thinks of Equillium (EQ) stock - MSN
Equillium (EQ) price target increased by 27.27% to 7.14 - MSN
Raymond James initiates Equillium stock coverage with strong buy By Investing.com - Investing.com Australia
Raymond James initiates Equillium stock coverage with strong buy - Investing.com
Chart Watch: Can Equillium Inc lead its sector in growthEarnings Trend Report & Step-by-Step Trade Execution Guides - baoquankhu1.vn
US Stocks Recap: Whats next for Equillium Inc stock2026 Snapshot & Weekly Setup with High ROI Potential - baoquankhu1.vn
Trade Report: Can Equillium Inc sustain earnings growthWeekly Trend Summary & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Market Pulse: Whats next for Equillium Inc stockWeekly Risk Report & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Equillium Announces Poster Presentations at IMMUNOLOGY2026, the Annual Meeting of the American Association of Immunologists - Bitget
Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists - The Manila Times
Equillium Announces Poster Presentations at - GlobeNewswire
Profit Recap: Can Equillium Inc sustain earnings growthMarket Weekly Review & Capital Protection Trading Alerts - baoquankhu1.vn
Aug EndMonth: Can Equillium Inc sustain earnings growthTrade Risk Report & Long-Term Investment Growth Plans - baoquankhu1.vn
Revenue Check: What is the target price for Equillium Inc stockWeekly Trade Analysis & Smart Allocation Stock Tips - baoquankhu1.vn
Equillium Inc selling stockholder may offer up to 18.9 million shares of common stock - marketscreener.com
Equillium (NASDAQ: EQ) registers 18.9M resale shares from RA Capital - Stock Titan
Equillium (EQ) Gains Overweight Rating with Promising Future Prospects - GuruFocus
Cantor Fitzgerald Begins Coverage on Equillium (NASDAQ:EQ) - MarketBeat
Equillium (EQ) Gains Overweight Rating with Promising Future Pro - GuruFocus
Cantor Fitzgerald Initiates Equillium(EQ.US) With Buy Rating, Announces Target Price $10 - Moomoo
Breakout Watch: What is the target price for Equillium Inc stock2026 Technical Overview & Precise Swing Trade Alerts - baoquankhu1.vn
Equillium (EQ) price target increased by 120.00% to 5.61 - MSN
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sahm
Equillium reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Reverse split range 1-for-2–1-for-20; Equillium (NASDAQ: EQ) seeks 400M cap - Stock Titan
Operating cash flow per share of Equillium, Inc. – LSX:A2N7B3 - TradingView
Cash per share of Equillium, Inc. – LSX:A2N7B3 - TradingView
Equillium Inc. 2025 Financial Review - AlphaStreet
EQUILLIUM ($EQ) Releases Q4 2025 Earnings - Moomoo
[EFFECT] Equillium, Inc. SEC Filing - Stock Titan
Equillium 2025 10-K: Advancing EQ504 AhR Modulator for Autoimmune & Inflammatory Disease Therapies - Minichart
RA CAPITAL MANAGEMENT, L.P. Acquires Significant Stake in Equillium Inc - GuruFocus
Equillium Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Equillium Inc. (NASDAQ:EQ) Reports In-Line Q4 Earnings, Highlights Pipeline Progress and Runway into 2029 - ChartMill
Equillium (EQ) Secures Financial Path to 2029, Focuses on Key Dr - GuruFocus
Equillium reports lower-than-expected Q4 net loss - TradingView
Equillium (NASDAQ:EQ) Announces Quarterly Earnings Results - MarketBeat
Equillium (NASDAQ: EQ) expands autoimmune pipeline and raises $65M in private financings - Stock Titan
Equillium, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Equillium (EQ) shifts to EQ504 focus, raises $85M and funds into 2029 - Stock Titan
Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights - globenewswire.com
Here’s What Roth Capital Thinks of Equillium (EQ) Stock - Insider Monkey
Equillium Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView
Equillium Inc (EQ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.69%
0.25%
자본화:
|
볼륨(24시간):